Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34354
Abstract: Patients with hematologic malignancies have impaired humoral immunity secondary to their malignancy and its treatment, placing them at risk of severe coronavirus disease‐19 (COVID‐19) infection and reduced response to vaccination. read more here.
Keywords: hematologic malignancies; vaccination; initial booster; covid ... See more keywords